Cargando…

The use of amisulpride in schizophrenic patients with resistant symptomatology

Detalles Bibliográficos
Autores principales:	Kalfas, Dimitrios, Markou, Sophia, Gkletsos, Apostolos, Parga, Maria, Karras, Theodoros
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2010
Materias:	Meeting Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2991820/ http://dx.doi.org/10.1186/1744-859X-9-S1-S135

Ejemplares similares

Is amisulpride associated less with neuroleptic malignant syndrome? Review and hypothesis
por: Peritogiannis, Vaios, et al.
Publicado: (2010)

Effect of Quetiapine in young schizophrenic patients with tardive dyskinesia
por: Singh, Piyush, et al.
Publicado: (2010)

PM391. THE USE OF AMISULPRIDE IN TREATMENT OF PATIENTS WITH RESIDUAL SCHIZOPHRENIA
por: Janjic, Vladimir, et al.
Publicado: (2016)

Reasons and patterns of hospitalization among schizophrenic patients in Greece: the Grace Study
por: Karadima, Dimitra, et al.
Publicado: (2010)

Evolution of symptoms with antipsychotic treatment in schizophrenic outpatients in Greece: the GRACE Study
por: Karadima, Dimitra, et al.
Publicado: (2010)

Priapism secondary to antipsychotic treatments with favorable response to amisulpride
por: Pérez Balaguer, A., et al.
Publicado: (2022)

The need for efficient long-term neuroleptic treatment in schizophrenic patients and the place of long acting injectable antipsychotics
por: Möller, Hans-Jurgen
Publicado: (2010)

Amisulpride Switching in Schizophrenic Patients Who Showed Suboptimal Effect and/or Tolerability to Current Antipsychotics in a Naturalistic Setting: An Explorative Study
por: Kim, Yongmin, et al.
Publicado: (2016)

Persistent hiccup as an adverse effect of amisulpride in a patient with first episode of psychosis.
por: Retsou, I., et al.
Publicado: (2023)

Hyperprolactinaemia with amisulpride
por: Raj, Rajnish, et al.
Publicado: (2008)

Adverse reaction to food screening test: new multiparametric ELISA kit for patients with gastrointestinal symptomatology linked to ingesting food
por: Faggian, Diego, et al.
Publicado: (2015)

Amisulpride-induced late-onset rabbit syndrome: Case report and literature review
por: Gundogmus, I., et al.
Publicado: (2022)

blind or schizophrenic but not both
por: Fatima Zahra, C., et al.
Publicado: (2022)

Schizophrenic or blind but not both
por: Chamsi, F.Z., et al.
Publicado: (2022)

Evaluation of social autonomy of schizophrenic patients
por: Zbidi, M., et al.
Publicado: (2023)

ADDICTION AND THE EVOLUTION AND COMPLIANCE OF SCHIZOPHRENIC PATIENTS
por: Azraf, F., et al.
Publicado: (2023)

Amisulpride induced mania
por: Aggarwal, Ashish, et al.
Publicado: (2010)

Title- Augmenting Amisulpride With Clozapine Leading To Akathisia: A Case Report
Publicado: (2022)

The use of amisulpride in the treatment of acute psychosis
por: Nuss, Philippe, et al.
Publicado: (2007)

Integrative psychotherapy of patients with schizophrenic spectrum disorders
por: Holm-Hadulla, R.M.
Publicado: (2021)

KSHV activation, human and viral IL-6 production, and other cytokine dysregulation: Association with the symptomatology of KSHV-associated multicentric Castleman’s disease
por: Polizzotto, Mark N, et al.
Publicado: (2010)

Amisulpride Reexposure and Tardive Dyskinesia
por: Sidana, Ajeet
Publicado: (2018)

Addictive behaviors in schizophrenic patients: Descriptive and analytical study
por: Bouali, W., et al.
Publicado: (2023)

EEG power spectrum analysis for Tunisian schizophrenic patients
por: Mnif, M., et al.
Publicado: (2023)

Brexpiprazole augmentation in a clozapine-resistant young schizophrenic patient: a successful case report.
por: Martiadis, V., et al.
Publicado: (2023)

The Symptomatology of Stridor in Diseases of Children
Publicado: (1914)

Amisulpride Augmentation in Schizophrenia Patients with Poor Response to Olanzapine: A 4-week, Randomized, Rater-Blind, Controlled, Pilot Study
por: Bahk, W.-M., et al.
Publicado: (2023)

Working memory and abstract thinking in patients with schizophrenic spectrum disorders
por: Popov, M., et al.
Publicado: (2021)

Coherence Abnormalities in Tunisian Schizophrenic patients: case-control study.
por: Mnif, M., et al.
Publicado: (2023)

F194. ASSOCIATION STUDY BETWEEN TREATMENT RESPONSE OF AMISULPRIDE AND DOPAMINE D3 RECEPTOR GENE POLYMORPHISMS
por: Lee, Kwanghun, et al.
Publicado: (2018)

Peculiarities of the anhedonia phenomenon in schizophrenic and affective disorders
por: Barkhatova, A., et al.
Publicado: (2023)

Neuropsychological and cerebral morphometric aspects of negative symptoms in schizophrenia: negative symptomatology is associated with specific mnestic deficits in schizophrenic patients
por: Hornig, Tobias, et al.
Publicado: (2014)

Safety and tolerability of antipsychotics: focus on amisulpride
por: Juruena, Mario F, et al.
Publicado: (2010)

Delayed-onset akathisia due to amisulpride
por: Atmaca, Murad, et al.
Publicado: (2011)

Treatment of Burning Mouth Syndrome With Amisulpride
por: Rodriguez-Cerdeira, Carmen, et al.
Publicado: (2012)

Tardive dyskinesia with low dose amisulpride
por: Tharoor, Hema, et al.
Publicado: (2013)

PT624. Clinical profiles of obsessive compulsive symptoms in schizophrenic patients
por: Koo, Min-Seong
Publicado: (2016)

Schizophrenic with childhood trauma: characterization of a Tunisian sample
por: Syrine, A., et al.
Publicado: (2023)

Relationship between emotional coping and depressive symptomatology
por: Delhom, I., et al.
Publicado: (2021)

Symptomatological Transversality and the Absence of Pathognomonic Symptoms in Psychiatry
por: Gomes, A. I., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_d5jop8h0i6732ork24qjh6ies7